On Christmas Day, billionaire Elon Musk shocked his followers by sharing a revealing post about his weight-loss journey. Known for his outspoken personality, Musk posted a photo of himself dressed as Santa Claus on X, formerly known as Twitter, with the caption “Ozempic Santa.” He then clarified in the replies that while the drug he’s taking is technically Mounjaro, not Ozempic, he chose the more familiar name for its ring.
Musk's Christmas Post and the Secret Behind His Weight Loss
Musk’s candidness about using medication to shed pounds left many of his followers surprised, as he has always been an advocate for pushing boundaries, both in business and personal health. The post showed the Tesla and SpaceX CEO in a classic red-and-white Santa costume, accompanied by the playful phrase "Ozempic Santa." While the internet quickly buzzed about the medication’s popularity among celebrities, Musk clarified that he was actually using Mounjaro, a drug related to Ozempic, for weight loss.
Ozempic and Mounjaro are both injectable medications originally designed to treat type-2 diabetes. They have gained significant attention as anti-obesity treatments due to their ability to help individuals lose weight when combined with diet and exercise. Mounjaro, which contains the active ingredient tirzepatide, was approved by the U.S. Food and Drug Administration (FDA) in 2022 and has become a common choice for those struggling with obesity-related health issues such as high blood pressure, high cholesterol, and sleep apnea.
Mounjaro vs. Ozempic: How They Work and Their Growing Popularity
Both Ozempic and Mounjaro work by regulating insulin levels and suppressing appetite. The drugs have been lauded for their effectiveness in weight loss, with many people using them to shed significant amounts of weight. Mounjaro is considered more powerful than Ozempic due to its unique combination of drugs, but both are widely regarded as effective in the treatment of obesity and related conditions.
Musk’s admission comes after he had previously shared that he lost 30 pounds by combining fasting with Ozempic/Wegovy, another brand of the same active ingredient, semaglutide. The revelation has sparked widespread discussion on social media about the ethics and long-term effectiveness of using prescription medications for weight loss. Musk’s fans have embraced his transparency, but others have raised concerns about the potential risks of using these drugs for non-medical reasons.
Public Reaction to Musk's Post on X
The reaction to Musk’s post has been swift and divided. While some praised Musk for his honesty, others expressed skepticism. Many social media users found it amusing that Musk, who is known for his eccentric behavior, would embrace the “Ozempic Santa” persona. However, others questioned the influence of such posts, particularly when they involve prescription drugs that are not typically intended for widespread, casual use.
Here’s what some Twitter users had to say:
- @TechGuru2024: “Elon Musk’s Ozempic confession is not surprising, but it's funny to see him embrace the Santa look. #OzempicSanta”
- @HealthyLiving123: “Musk using Ozempic to lose weight? Must be nice to have access to these treatments. #Mounjaro #WeightLoss”
- @TheRealChrisJ: “I love how Musk is always willing to share his secrets, even the ones that might raise some eyebrows.”
- @GadgetsAndGains: “Do people realize how dangerous it can be to promote these meds for weight loss without medical supervision? #OzempicSanta”
- @MindYourBusiness21: “Elon Musk and Mounjaro, now that’s an unexpected combo. #BusinessAndHealth”
- @FuturiTechFan: “Musk’s transparency about his weight-loss methods is refreshing, but it’ll definitely stir the pot. #OzempicSanta”
What's Next for Musk and His Health Journey?
Musk’s weight-loss journey is far from over. As he continues to make headlines with his personal and professional endeavors, including his involvement in the newly created Department of Government Efficiency (DOGE), it remains to be seen how his decision to openly embrace weight-loss treatments will affect his public image. In the meantime, Musk’s followers can expect more surprises as he prepares for a major role in the upcoming administration and his next business ventures.


U.S.-Russia Talks Leave Ukraine Peace Efforts Uncertain
Trump Administration Halts Immigration, Green Card, and Citizenship Processing for 19 Countries
Taiwan Opposition Criticizes Plan to Block Chinese App Rednote Over Security Concerns
U.S. Repatriation Flight Carrying 266 Venezuelan Migrants Lands in Caracas
Trump and Lula Discuss Trade, Sanctions, and Security in “Productive” Phone Call
U.S. Defense Chief Pete Hegseth Defends Controversial Second Strike on Suspected Drug-Smuggling Vessel
Hong Kong Faces Low Turnout in “Patriots-Only” Election Amid Public Grief After Deadly Fire
Australia and Japan Strengthen Defence Cooperation Amid Rising Regional Tensions
China’s Expanding Maritime Military Presence Alarms Taiwan and Japan
IMF Deputy Dan Katz Visits China as Key Economic Review Nears
Michael Dell Pledges $6.25 Billion to Boost Children’s Investment Accounts Under Trump Initiative
Honduras Election Turmoil Deepens as Nasralla Alleges Fraud in Tight Presidential Race
Israel Receives Body of Deceased Hostage as Rafah Crossing Reopening Hinges on Final Returns
UN General Assembly Demands Russia Return Ukrainian Children Amid Ongoing Conflict
California Launches Portal for Reporting Alleged Misconduct by Federal Immigration Agents
UN Chief Says Gaza Operation “Fundamentally Wrong” as Concerns Over War Crimes Grow 



